MetLife Investment Management, LLC
Position in AXSM — Axsome Therapeutics, Inc.
CIK 1529735
Whippany, NJ
Position in AXSM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$21,946,567
-$3,853,490 QoQ
Shares Held
89,662
-41.3% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#76
of 494 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $430,145,499 across 249 Biotechnology names. AXSM ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
402,605 | $31,511,893 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
90,543 | $30,312,890 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
58,072 | $28,846,104 | |
| 4 | FTRE |
Fortrea Holdings Inc.
|
1,362,169 | $23,701,740 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
This page
|
89,662 | $21,946,567 | |
| 6 | IMNM |
Immunome Inc.
|
859,076 | $18,203,820 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,880 | $14,266,595 | |
| 8 | CYTK |
Cytokinetics Inc
|
140,046 | $11,930,518 |
All Filings in AXSM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,946,567 | 89,662 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $25,800,057 | 152,645 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $30,112,039 | 164,871 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $23,964,271 | 197,318 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $19,224,879 | 184,164 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $20,871,521 | 178,955 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $1,884,856 | 22,277 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,891,314 | 21,045 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,694,122 | 21,045 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,476,539 | 18,503 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,472,653 | 18,503 | Shares | Defined | 2024-04-22 | |
| 2023-09-30 | $1,293,174 | 18,503 | Shares | Defined | 2024-05-09 | |
| 2023-06-30 | $1,237,501 | 17,221 | Shares | Defined | 2024-04-29 | |
| 2023-03-31 | $1,042,392 | 16,900 | Shares | Defined | 2024-05-09 | |
| 2022-12-31 | $1,303,497 | 16,900 | Shares | Defined | 2024-05-10 | |
| 2022-09-30 | $729,180 | 16,342 | Shares | Defined | 2024-05-10 | |
| 2022-06-30 | $664,428 | 17,348 | Shares | Defined | 2024-05-10 | |
| 2022-03-31 | $718,033 | 17,348 | Shares | Defined | 2024-05-10 | |
| 2021-12-31 | $412,142 | 10,909 | Shares | Defined | 2024-05-17 | |
| 2021-09-30 | $359,560 | 10,909 | Shares | Defined | 2024-05-17 | |
| 2021-06-30 | $735,921 | 10,909 | Shares | Defined | 2024-05-17 | |
| 2021-03-31 | $617,667 | 10,909 | Shares | Defined | 2024-05-17 | |
| 2020-12-31 | $888,756 | 10,909 | Shares | Defined | 2024-05-24 | |
| 2020-09-30 | $877,230 | 12,312 | Shares | Defined | 2024-05-24 | |
| 2020-06-30 | $1,013,031 | 12,312 | Shares | Defined | 2024-05-24 | |
| 2020-03-31 | $684,310 | 11,632 | Shares | Defined | 2023-07-12 | |
| No filing history on record for this holder in this stock. | ||||||